<SEC-DOCUMENT>0000950170-25-015473.txt : 20250206
<SEC-HEADER>0000950170-25-015473.hdr.sgml : 20250206
<ACCEPTANCE-DATETIME>20250206164642
ACCESSION NUMBER:		0000950170-25-015473
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250206

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CVRx, Inc.
		CENTRAL INDEX KEY:			0001235912
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92669
		FILM NUMBER:		25598102

	BUSINESS ADDRESS:	
		STREET 1:		9201 WEST BROADWAY AVENUE
		STREET 2:		SUITE 650
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55445
		BUSINESS PHONE:		7634162850

	MAIL ADDRESS:	
		STREET 1:		9201 WEST BROADWAY AVENUE
		STREET 2:		SUITE 650
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55445

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CVRX INC
		DATE OF NAME CHANGE:	20030527

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vensana Capital I GP, LLC
		CENTRAL INDEX KEY:			0001854073
		ORGANIZATION NAME:           	
		IRS NUMBER:				832530344
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		3601 W 76TH ST
		STREET 2:		SUITE 20
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55435
		BUSINESS PHONE:		650-843-5000

	MAIL ADDRESS:	
		STREET 1:		3601 W 76TH ST
		STREET 2:		SUITE 20
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55435
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <previousAccessionNumber>0001193125-24-025578</previousAccessionNumber>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001854073</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>3</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.01 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/31/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001235912</issuerCik>
        <issuerName>CVRx, Inc.</issuerName>
        <issuerCusip>126638105</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">9201 West Broadway Avenue</street1>
          <street2 xmlns="http://www.sec.gov/edgar/common">Suite 650</street2>
          <city xmlns="http://www.sec.gov/edgar/common">Minneapolis</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MN</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">55445</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Vensana Capital I GP, LLC</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>1711355</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>1711355</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1711355</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>7.1</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>All such shares are held of record by Vensana I (as defined in Item 2(a) of the Original Schedule 13G (as defined in Item 2(a) below)). Vensana GP I (as defined in Item 2(a) of the Original Schedule 13G) is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Percentage based on 24,263,663 shares of Common Stock (as defined in Item 2(d) of the Original Schedule 13G) outstanding as of October 25, 2024, as reported by the Issuer in its Form 10-Q for the quarter ended September 30, 2024, filed with the Securities and Exchange Commission (the "Commission") on November 1, 2024 (the "Form 10-Q").</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Vensana Capital I, L.P.</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>1711355</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>1711355</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1711355</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>7.1</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>All such shares are held of record by Vensana I. Vensana GP I is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Percentage based on 24,263,663 shares of Common Stock outstanding as of October 25, 2024, as reported by the Issuer in the Form 10-Q.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Kirk Nielsen</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>49379</soleVotingPower>
        <sharedVotingPower>1711355</sharedVotingPower>
        <soleDispositivePower>49379</soleDispositivePower>
        <sharedDispositivePower>1711355</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1760734</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>7.2</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>All such shares of Common Stock reported in rows 5 and 7 are subject to stock option awards that have been granted to Kirk Nielsen in his capacity as a director of the Issuer and that are exercisable as of or within 60 days of filing this Amendment (as defined in Item 2(a) below).

All such shares reported in rows 6 and 8 are held of record by Vensana I. Vensana GP I is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Percentage based on 24,313,042 shares of Common Stock, calculated as follows: (i) 49,379 shares of Common Stock subject to stock option awards that have been granted to Kirk Nielsen in his capacity as a director of the Issuer and that are exercisable as of or within 60 days of the filing of this Amendment plus (ii) 24,263,663 shares of Common Stock outstanding as of October 25, 2024, as reported by the Issuer in the Form 10-Q.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Peter Justin Klein</reportingPersonName>
      <memberGroup>b</memberGroup>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0</soleVotingPower>
        <sharedVotingPower>1711355</sharedVotingPower>
        <soleDispositivePower>0</soleDispositivePower>
        <sharedDispositivePower>1711355</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1711355</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>7.1</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>All such shares are held of record by Vensana I. Vensana GP I is the general partner of Vensana I and may be deemed to have voting, investment and dispositive power with respect to these securities. Kirk Nielsen and Peter Justin Klein are the managing directors of Vensana GP I and may each be deemed to share voting, investment and dispositive power with respect to these securities.

Percentage based on 24,263,663 shares of Common Stock outstanding as of October 25, 2024, as reported by the Issuer in the Form 10-Q.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>CVRx, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>9201 West Broadway Avenue, Suite 650, Minneapolis, Minnesota, 55445</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Amendment No. 3 (this "Amendment") amends and supplements the Schedule 13G originally filed by the Reporting Persons with the Commission on February 10, 2022 as amended by Amendment No. 1 filed with the Commission on February 3, 2023 and Amendment No. 2 filed with the Commission on February 6, 2024 (collectively, the "Original Schedule 13G"). Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13G remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Amendment have the meanings ascribed to them in the Original Schedule 13G.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>To Come</principalBusinessOfficeOrResidenceAddress>
        <citizenship>To Come</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See Row 9 of the cover page for each Reporting Person and the corresponding comments.*</amountBeneficiallyOwned>
        <classPercent>See Row 11 of the cover page for each Reporting Person and the corresponding comments.*</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See Row 5 of the cover page for each Reporting Person and the corresponding comments.*</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See Row 6 of the cover page for each Reporting Person and the corresponding comments.*</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See Row 7 of the cover page for each Reporting Person and the corresponding comments.*</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See Row 8 of the cover page for each Reporting Person and the corresponding comments.*

* Except to the extent of his, her or its pecuniary interest therein, each Reporting Person disclaims beneficial ownership of such shares of Common Stock, except for the shares, if any, such Reporting Person holds of record.</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>N</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>N</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>N</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Vensana Capital I GP, LLC</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Steven Schwen*</signature>
        <title>Steven Schwen/Attorney-in-Fact</title>
        <date>02/06/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Vensana Capital I, L.P.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Steven Schwen*</signature>
        <title>Steven Schwen/Attorney-in-Fact of Vensana Capital I GP, LLC, the General Partner of Vensana Capital I, L.P.</title>
        <date>02/06/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Kirk Nielsen</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Steven Schwen*</signature>
        <title>Steven Schwen/Attorney-in-Fact</title>
        <date>02/06/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Peter Justin Klein</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Steven Schwen*</signature>
        <title>Steven Schwen/Attorney-in-Fact</title>
        <date>02/06/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureComments>*This Amendment was executed pursuant to a Power of Attorney. Note that copies of all applicable Powers of Attorney are already on file with the appropriate agencies.</signatureComments>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
